Open AccessDexrazoxane decreases the cardiotoxic effects of doxorubicin in osteosarcoma patients without increasing mortality from secondary malignant neoplasms
Author(s) -
Thomas S. Przybycien
Publication year - 2021
Publication title -
clinical research in practice the journal of team hippocrates
Language(s) - English
Resource type - Journals
ISSN - 2379-4550
DOI - 10.22237/crp/1622160360
Subject(s) - dexrazoxane , osteosarcoma , medicine , doxorubicin , blood cancer , chemotherapy , oncology , cancer , clinical oncology , cancer research , breast cancer , anthracycline
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom